Paloma Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,306
| Closed | -$381K | – | 2169 |
|
|
2021
Q2 | $381K | Sell |
2,306
-19,694
| -90% | -$3.29M | 0.01% | 1173 |
|
|
2021
Q1 | $3.37M | Buy |
+22,000
| New | +$2.99M | 0.07% | 243 |
|
|
2020
Q4 | – | Sell |
-6,227
| Closed | -$632K | – | 2438 |
|
|
2020
Q3 | $632K | Buy |
6,227
+1,827
| +42% | +$186K | 0.02% | 1007 |
|
|
2020
Q2 | $428K | Buy |
+4,400
| New | +$409K | 0.01% | 1299 |
|
|
2020
Q1 | – | Sell |
-13,963
| Closed | -$1.55M | – | 2326 |
|
|
2019
Q4 | $1.55M | Sell |
13,963
-850
| -6% | -$87.4K | 0.02% | 717 |
|
|
2019
Q3 | $1.47M | Buy |
14,813
+272
| +2% | +$27K | 0.03% | 563 |
|
|
2019
Q2 | $1.44M | Buy |
14,541
+3,799
| +35% | +$363K | 0.02% | 552 |
|
|
2019
Q1 | $1.19M | Buy |
+10,742
| New | +$1.12M | 0.03% | 650 |
|
|
2018
Q4 | – | Sell |
-6,100
| Closed | -$673K | – | 1922 |
|
|
2018
Q3 | $673K | Sell |
6,100
-120,862
| -95% | -$12.6M | 0.01% | 903 |
|
|
2018
Q2 | $11.9M | Buy |
126,962
+119,315
| +1,560% | +$10.3M | 0.22% | 76 |
|
|
2018
Q1 | $634K | Buy |
+7,647
| New | +$679K | 0.01% | 1240 |
|
|
2017
Q4 | – | Sell |
-6,212
| Closed | -$474K | – | 2433 |
|
|
2017
Q3 | $474K | Buy |
+6,212
| New | +$469K | 0.01% | 1551 |
|
|
2017
Q2 | – | Sell |
-14,684
| Closed | -$958K | – | 2524 |
|
|
2017
Q1 | $958K | Buy |
14,684
+842
| +6% | +$49.6K | 0.01% | 1261 |
|
|
2016
Q4 | $763K | Buy |
13,842
+1,942
| +16% | +$107K | 0.01% | 1309 |
|
|
2016
Q3 | $672K | Sell |
11,900
-4,325
| -27% | -$212K | 0.01% | 1264 |
|
|
2016
Q2 | $678K | Buy |
16,225
+11,014
| +211% | +$507K | 0.01% | 1397 |
|
|
2016
Q1 | $223K | Buy |
+5,211
| New | +$220K | ﹤0.01% | 1649 |
|
Other funds holding PRAH
Paloma Partners's PRAH Position: Q3 2021 in Review
Paloma Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,306 shares — an estimated $381K sold.
Paloma Partners first reported a position in PRAH in Q1 2016 and held it in 17 quarters. The position peaked at $11.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Paloma Partners reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Paloma Partners sold 2,306 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $381K.
- Paloma Partners first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 17 quarters.
- Paloma Partners's PRA Health Sciences, Inc. position peaked at $11.9M in Q2 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.